G01N 2333/165
Coronaviridae
Official title: Coronaviridae, e.g. avian infectious bronchitis virus
G01N2333/165 (Coronaviridae) appears on 234 US grants and 1,018 published applications in this corpus.
Search patents in G01N- Granted patents
- 234
- Published applications
- 1,018
- Assignees
- 653
- Inventors
- 3,168
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 14 |
| 2006 | 0 | 12 |
| 2007 | 0 | 6 |
| 2008 | 1 | 3 |
| 2009 | 6 | 4 |
| 2010 | 4 | 3 |
| 2011 | 1 | 3 |
| 2012 | 0 | 1 |
| 2013 | 3 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 4 |
| 2016 | 2 | 4 |
| 2017 | 1 | 2 |
| 2018 | 3 | 5 |
| 2019 | 2 | 4 |
| 2020 | 7 | 3 |
| 2021 | 28 | 111 |
| 2022 | 22 | 152 |
| 2023 | 32 | 275 |
| 2024 | 33 | 214 |
| 2025 | 33 | 122 |
| 2026 | 51 | 71 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)6 Oct 2026US 12,754,184 B2Navigo Proteins GmbH
- Quinine and its use to generate innate immune response29 Sep 2026US 12,746,236 B2The Trustees of the University of Pennsylvania
- Method for accumulating microscopic objects, and method for detecting microscopic objects using same29 Sep 2026US 12,748,113 B2University Public Corporation Osaka
- Antigen for 2019 novel Coronavirus and detection use thereof15 Sep 2026US 12,736,543 B2Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Compositions and methods for the detection and treatment of SARS-CoV-2 virus infection1 Sep 2026US 12,724,030 B2Georgia Tech Research Corporation
- Ace2 inhibition assay for evaluation of vaccine immunogenicity8 Oct 2026US 2026/0309709 A1Novavax, Inc.
- Identifying antibody virus-neutralization status8 Oct 2026US 2026/0309711 A1
- Method for detecting and quantifying exosomes1 Oct 2026US 2026/0298935 A1Therawis Diagnostics GmbH
- Coronavirus vaccines inducing broad immunity against variants24 Sep 2026US 2026/0284179 A1Cambridge Enterprise Limited
- Diagnostics method for detecting microparticles17 Sep 2026US 2026/0276631 A1Shero Diagnostics
Most cited
By later US patents
- Recombinant baculovirus and virus-like particle58US 7,527,967 B2Academia Sinica · 2009
- Binding molecules against SARS-coronavirus and uses thereof58US 7,696,330 B2Crucell Holland B. V. · 2010
- Strain of SARS-associated coronavirus and applications thereof18US 8,343,718 B2Centre National De La Recherche Scientifique · 2013
- Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use15US 10,301,377 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2019
- Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics14US 7,803,918 B2Amsterdam Institute of Viral Genomics B.V. · 2010